Enzo Biochem (ENZ) Reports In-Line Q4 EPS

Enzo Biochem (NYSE: ENZ) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $25.7 million versus the consensus estimate of $24.6 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital